Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $29.75 USD
Change Today -0.68 / -2.23%
Volume 1.3M
SRPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - SAREPTA THERAPEUTICS INC (SRPT)

Sarepta Therapeutics, Inc. to Report Q1, 2015 on May 07, 2015
CapIQ 05/07/2015 12:00 PM ET
Sarepta Therapeutics, Inc. to Report Q4, 2014 on Feb 26, 2015
CapIQ 05/07/2015 12:00 PM ET
Sarepta Therapeutics, Inc. to Report Q3, 2014 on Nov 06, 2014
CapIQ 05/07/2015 12:00 PM ET

2013 revenues at Sarepta Therapeutics, Inc. totaled $14.2M USD, while annual losses equaled $2.63 per share.

Quarterly Earnings & Estimates - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Quarterly Earnings

Sarepta Therapeutics, Inc. reported 2nd quarter 2014 losses of $0.61 per share on 08/9/2014.

Annual Earnings & Estimates - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Annual Earnings

Sarepta Therapeutics, Inc. reported annual 2013 losses of $2.63 per share on 03/1/2014.

Quarterly Revenues - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Quarterly Revenues

Sarepta Therapeutics, Inc. had 2nd quarter 2014 revenues of $2.6M USD. This missed the $4.0M USD consensus estimate of the 13 analysts following the company. This was -12.5% below the prior year's 2nd quarter results.

Annual Revenues - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Annual Revenues

Sarepta Therapeutics, Inc. had revenues for the full year 2013 of $14.2M USD. This was -61.9% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRPT:US $29.75 USD -0.68

SRPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.75 AUD +0.025
Galena Biopharma Inc $1.73 USD +0.03
Regulus Therapeutics Inc $10.54 USD -0.42
Silence Therapeutics PLC 298.00 GBp -6.00
View Industry Companies
 

Industry Analysis

SRPT

Industry Average

Valuation SRPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 342.7x
Price/Book 6.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 296.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.